Last reviewed · How we verify

NCT04583137

Buffered vs Plain Lidocaine for Local Nasal Anesthesia

Status unknown EARLY_PHASE1 Last updated 12 October 2020
What this trial tests

EARLY_PHASE1 trial testing Lidocain in Anesthesia, Local in 80 participants. Status unknown.

Timeline
1 November 2020
Primary endpoint
1 November 2022
1 March 2023

Quick facts

Lead sponsorKfir Siag
PhaseEARLY_PHASE1
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposediagnostic
Enrollment80
Start date1 November 2020
Primary completion1 November 2022
Estimated completion1 March 2023
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Kfir Siag

Who can join

Adults 18 to 65, any sex, with Anesthesia, Local. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Transnasal Fiberoptic Laryngoscopy (TFL) is a common procedure in the otolaryngology clinic for the examination of vocal cord appearance and function, inspection and follow up of benign and malignant lesions, and investigating foreign body ingestion. There are many forms for applying preprocedural local nasal anesthesia such as atomizers, nebulizers, spray, soaked pads, or local anesthetic gel application. This study compares the effect of buffered versus plain lidocaine for local nasal anesthesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Lidocain

Trials testing the same drug.

Other recruiting trials for Anesthesia, Local

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04583137.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing